I have never read the company saying they " needed" 3D reactors in order to commercialise, they have said they are developing them as a requirement ( to reduce cost, and increase product )
Increase of product happens after commercialisation, not before there is a product.
FDA have not inspected and approved a 3D bioreactor as far as we are aware.
All indications I have read - it will commercialize under 2D.
I have never read the company saying they " needed" 3D reactors...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.78 |
Change
0.255(16.7%) |
Mkt cap ! $2.032B | |||
| Open | High | Low | Value | Volume |
| $1.74 | $1.83 | $1.71 | $27.76M | 15.59M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30000 | $1.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.79 | 48074 | 4 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |